Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2128 of 6351
-
Two-in-One heart fix: bypass plus stent may beat either alone
Disease control CompletedThe purpose of the registry is to assess results of combined operative and catheter based (hybrid procedure) treatment of patients with significant coronary artery disease using essential clinical and angiographic parameters. Based on existing literature we expect the results of…
Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Supercharged immune cells take on viruses in transplant patients
Disease control CompletedThe main purpose of this project is to evaluate the efficiency of the injection of CD4 and CD8+ T cell anti-Cytomegalovirus (CMV) on blood viral replication of CMV, 21 days after the first injection (adenovirus infection is not enough usual, especially in adults, to be used for t…
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 13:25 UTC
-
New surgery for rectal cancer could cut leak risk and stoma need
Disease control CompletedHypothesis: In France, approximately 12,000 new rectal cancers are diagnosed each year. Frequency is one and a half times higher in men than in women. The average age of diagnosis is 65. Unlike colon cancer, technical management remains challenging with unresolved operating diff…
Phase 2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 26, 2026 14:02 UTC
-
New chemo cocktail shows promise for rare childhood brain cancer
Disease control CompletedThis study will look to see how well patients with relapsed or recurrent intracranial germ cell tumors respond to the new combination of chemotherapy (in induction)of Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) followed by consolidation chemotherapy and autologous stem cell …
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Nasal vaccine could shield newborns from whooping cough
Vaccine CompletedThe purpose of this study is to evaluate the safety and immunogenicity of a new live attenuated vaccine against whooping-cough. It is a phase1, single centre, dose-escalating, placebo-controlled study on a genetically modified B. pertussis strain given as a single intranasal dose…
Phase 1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Vaccine
Last updated Jun 27, 2026 08:03 UTC
-
Mini transplant shows promise for blood cancers – but trial ended early
Disease control Stopped earlyThis research is being done to learn more about reduced-intensity bone marrow transplantation (BMT), also known as a "mini" transplant for patients with blood cancers, using bone marrow from a relative. The main goal of the study is to determine how quickly the donor's bone marr…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a tape measure around the neck predict a tough airway?
Diagnosis CompletedThe circumference of a person's neck is a useful predictor of difficulty of insertion of a breathing tube.
Sponsor: CAMC Health System • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Experimental vaccine trains immune system to fight multiple cancers
Disease control CompletedThe purpose of this study is to find out what effects (good and bad) that a cancer vaccine has on you and your cancer. The cancer vaccine is called Ad5 \[E1-, E2b-\]-CEA(6D)or ETBX-011 and is made by Etubics. This vaccine is based on a virus called an adenovirus but it has been c…
Phase 1/2 • Sponsor: NantCell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a simple gas save marginal liver grafts?
Disease control CompletedThis study is being done to determine if patients receiving (iNO) will have increased liver function and less damage from IR than patients who do not receive (iNO).
Phase 2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Massive study tests everyday supplements against autoimmune disease and aching knees
Disease control CompletedThe VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Sharper radiation beams aim to tame High-Risk prostate cancer
Disease control OngoingThe purpose of this study is to find out the effects (good and bad) of using newer technologies that allow very precise delivery of radiation. These newer technologies are Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental drug pair targets tough leukemias
Disease control CompletedThis phase I clinical trial is studies the side effects and best dose of giving veliparib together with temozolomide in treating patients with acute leukemia. Veliparib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemo…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Scientists reprogram immune cells to attack prostate cancer
Disease control OngoingThis is a phase I study which will test the safety of different doses of the patients own immune cells which have been changed to help recognize and destroy the cancer cells. The investigators want to find out what effects, good and/or bad, it has on the body and on the prostate …
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Proton beam may spare healthy brain tissue in young tumor patients
Disease control OngoingThe purpose of this research study is to determine if radiation using proton beam therapy will kill the germ cell tumor in the participant's central nervous system. This type of radiation has been used previously on many patients with different types of cancers. There are two typ…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Triple drug cocktail targets tough pancreatic cancer
Disease control CompletedGATE 1 is an open-label, non-comparative, multicentric study evaluating the efficacy and tolerance of the combined use of Gemcitabine, Trastuzumab and Erlotinib as a first-line chemotherapy in metastatic pancreatic cancer patients. The patients will be treated intravenously with…
Phase 2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New device hopes to spark recovery in stroke patients
Disease control Recruiting nowThe purpose of this research is to determine if two non-invasive brain stimulation techniques, muscle stimulation of the arm and neuro-stimulation through the tongue, can increase the extent of stroke recovery.
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Heat zap after lumpectomy may cut breast cancer return and second surgeries
Disease control OngoingThe purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservati…
Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New cocktail aims to tackle tough myeloma cases
Disease control CompletedThe primary objective of this study is to: • Determine the maximum tolerated dose of thalidomide used in conjunction with dose-intense melphalan, bortezomib and autologous (syngeneic) HSC support in the salvage therapy of patients who failed a prior treatment with dose-intense m…
Phase 1/2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Two-Drug combo shows promise for Hard-to-Treat uterine cancer
Disease control OngoingThe goal of this clinical research study is to learn if the combination of RAD001 (everolimus) and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Your Child's genes: a new clue in fighting a rare cancer?
Knowledge-focused CompletedTo study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC